FunPep Company Limited

4881

JP3802640007

Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 07:00:00 10/05/2024 BST			5-day change	1st Jan Change
159 ^JPY	+1.27%		+8.16%	+17.78%

03-21	FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI
03-04	FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI

FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm

December 12, 2021

ON December 13, 2021, FunPep Company Limited closed the transaction.

Latest news about FunPep Company Limited

FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	03-20	CI
FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	03-03	CI
FunPep Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	11-14	CI
FunPep Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
FunPep Company Limited completed the acquisition of Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	30/09/22	CI
FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	13/07/22	CI
FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	12/12/21	CI
FunPep Company Limited announced that it expects to receive ?3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	25/11/21	CI
FunPep Company Limited has completed an IPO in the amount of ¥1.780805 billion.	25/12/20	CI
FunPep Company Limited has filed an IPO.	20/11/20	CI
FunPep Company Limited has withdrawn its IPO.	14/11/20	CI
FunPep Company Limited has filed an IPO.	18/11/19	CI
FunPep Co., Ltd. announced that it has received ¥460 million in funding from a group of investors	04/10/18	CI
FunPep Co., Ltd. announced that it has received ¥100 million in funding from OSAKA University Venture Capital Co., Ltd.	13/04/16	CI
Funpep Co., Ltd. announced that it has received funding from Japan Science And Technology Agency and other investors.	29/11/15	CI

FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.

Sector

Biotechnology & Medical Research

Calendar

12/05/2024 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
FUNPEP COMPANY LIMITED	+17.78%	26.53M
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research